Savara Inc. (SVRA)
NASDAQ: SVRA
· Real-Time Price · USD
3.58
-0.02 (-0.56%)
At close: Oct 16, 2025, 3:59 PM
3.65
1.96%
After-hours: Oct 16, 2025, 06:31 PM EDT
-0.56% (1D)
| Bid | 3.57 |
| Market Cap | 618.76M |
| Revenue (ttm) | 272K |
| Net Income (ttm) | -110.33M |
| EPS (ttm) | -0.51 |
| PE Ratio (ttm) | -7.02 |
| Forward PE | -7.04 |
| Analyst | Buy |
| Dividends | n/a |
| Ask | 3.58 |
| Volume | 1,593,936 |
| Avg. Volume (20D) | 1,324,240 |
| Open | 3.64 |
| Previous Close | 3.60 |
| Day's Range | 3.56 - 3.75 |
| 52-Week Range | 1.89 - 4.29 |
| Beta | 0.46 |
| Ex-Dividend Date | n/a |
About SVRA
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol SVRA
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for SVRA stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts4 months ago
+9.79%
Savara shares are trading higher. Guggenheim maint...
Unlock content with
Pro Subscription
4 months ago
-31.69%
Savara shares are trading lower after the company announced it received a refusal to file letter from the FDA for its biologics license application.
